Confidential Portions Omitted) CO-EXCLUSIVE MANUFACTURING AND SUPPLY AGREEMENT by and among ANGIOTECH PHARMACEUTICALS, INC., SURGICAL SPECIALTIES PUERTO RICO, INC., ANGIOTECH PUERTO RICO, INC., ANGIOTECH INTERNATIONAL AG, QUILL MEDICAL, INC. and...Exclusive Manufacturing and Supply Agreement • November 13th, 2012 • Angiotech Pharmaceuticals Inc • Surgical & medical instruments & apparatus • New York
This CO-EXCLUSIVE MANUFACTURING AND SUPPLY AGREEMENT, dated as of April 4, 2012, is made and entered into by and among Angiotech Pharmaceuticals, Inc., a corporation formed under the Laws of British Columbia with offices at 1618 Station Street, Vancouver, B.C., Canada, V6A 1B6 (the “Company”), Surgical Specialties Puerto Rico, Inc., a Puerto Rico corporation with offices at RD. 459 KM 0.6, Montana Industrial Park, Aguadilla, Puerto Rico (“Manufacturing Subsidiary 1”), Angiotech Puerto Rico, Inc., a Puerto Rico corporation with offices at RD. 459 KM 0.6, Montana Industrial Park, Aguadilla, Puerto Rico, 00605 ((“Manufacturing Subsidiary 2”, and together with the Company and Manufacturing Subsidiary 1, “Manufacturer”), each of them is severally referred to as a “Manufacturer Party”), Ethicon, LLC, a Delaware limited liability company with offices at 475 Calle C Suite 401, Los Frailes Industrial Park, Guaynabo, PR. 00969 (“Distributor” and together with Manufacturer, the “Parties”)), and s
EXHIBIT 10.1Exclusive Manufacturing and Supply Agreement • October 9th, 1997 • North American Scientific Inc • In vitro & in vivo diagnostic substances • Delaware
EXCLUSIVE MANUFACTURING AND SUPPLY AGREEMENT THIS AGREEMENT made as of December 18, 1998, between THE HOFFMASTER DIVISION OF THE FONDA GROUP, INC., a Delaware corporation, ("Hoffmaster") and CREATIVE EXPRESSIONS GROUP, INC., a Delaware corporation,...Exclusive Manufacturing and Supply Agreement • February 10th, 1999 • Fonda Group Inc • Paperboard containers & boxes • Wisconsin
EX-10.29 3 w20549a3exv10w29.htm EX-10.29Exclusive Manufacturing and Supply Agreement • May 5th, 2020
Exhibit 10.29 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. RU-0211 EXCLUSIVE MANUFACTURING AND SUPPLY AGREEMENT This RU-0211 EXCLUSIVE MANUFACTURING AND SUPPLY AGREEMENT (“Agreement”) is made this 24th day of June 2005 (the “Effective Date”), by and among Sucampo Pharma Europe Ltd., a corporation organized and existing under the laws of United Kingdom and having its principal office at 78 Cannon Street, London EC4N6NQ, United Kingdom (“SPE”), and R-Tech Ueno Ltd., a corporation organized and existing under the laws of Japan and having its principal office at 1-1-7 Uchisaiwai-cyo, Chiyoda-ku, Tokyo 100-0011, Japan (“RTU”) (each referred to herein as a “Party” and collectively as the “Parties”). WHEREAS, SPE and RTU executed the Basic Exclusive Supply Agreement Term Sheet dated March 30, 2005 (the “Term Sheet”), which sets forth the basic terms and conditions under which RTU shall manufacture and supply certa
